NCT03712735View on ClinicalTrials.gov

Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women

PHASE4CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

March 2, 2021

Study Completion Date

March 2, 2021

Conditions
Labor Pain
Interventions
DRUG

Bupivacaine 0.08% - fentanyl 2mcg

In each arm, bupivacaine and fentanyl are being delivered at different intervals and rates for the maintenance of labor analgesia.

Trial Locations (1)

V6H 3N1

BC Women's Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT03712735 - Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women | Biotech Hunter | Biotech Hunter